[H]C12Oc3c(O)ccc4c3C13CCN(CC=C)C([H])(C4)C3(O)CCC2=NN=C1CCC2(O)C3([H])Cc4ccc(O)c5c4C2(CCN3CC=C)C1([H])O5
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?